Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10570304rdf:typepubmed:Citationlld:pubmed
pubmed-article:10570304lifeskim:mentionsumls-concept:C0024109lld:lifeskim
pubmed-article:10570304lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:10570304lifeskim:mentionsumls-concept:C0225336lld:lifeskim
pubmed-article:10570304lifeskim:mentionsumls-concept:C0079633lld:lifeskim
pubmed-article:10570304lifeskim:mentionsumls-concept:C0007578lld:lifeskim
pubmed-article:10570304lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:10570304lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:10570304lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:10570304lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:10570304lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:10570304lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:10570304lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:10570304lifeskim:mentionsumls-concept:C0065067lld:lifeskim
pubmed-article:10570304lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:10570304pubmed:issue11lld:pubmed
pubmed-article:10570304pubmed:dateCreated1999-12-20lld:pubmed
pubmed-article:10570304pubmed:abstractTextCell adhesion molecule expression (CAM) and IL-8 release in lung microvascular endothelium facilitate neutrophil accumulation in the lung. This study investigated the effects of lipoteichoic acid (LTA), a cell wall component of Gram-positive bacteria, alone and with LPS or TNF-alpha, on CAM expression and IL-8 release in human lung microvascular endothelial cells (HLMVEC). The concentration-dependent effects of Staphylococcus aureus (S. aureus) LTA (0.3-30 microg/ml) on ICAM-1 and E-selectin expression and IL-8 release were bell shaped. Streptococcus pyogenes (S. pyogenes) LTA had no effect on CAM expression, but caused a concentration-dependent increase in IL-8 release. S. aureus and S. pyogenes LTA (30 microg/ml) abolished LPS-induced CAM expression, and S. aureus LTA reduced LPS-induced IL-8 release. In contrast, the effects of S. aureus LTA with TNF-alpha on CAM expression and IL-8 release were additive. Inhibitory effects of LTA were not due to decreased HLMVEC viability, as assessed by ethidium homodimer-1 uptake. Changes in neutrophil adhesion to HLMVEC paralleled changes in CAM expression. Using RT-PCR to assess mRNA levels, S. aureus LTA (3 microg/ml) caused a protein synthesis-dependent reduction (75%) in LPS-induced IL-8 mRNA and decreased the IL-8 mRNA half-life from >6 h with LPS to approximately 2 h. These results suggest that mechanisms exist to prevent excessive endothelial cell activation in the presence of high concentrations of bacterial products. However, inhibition of HLMVEC CAM expression and IL-8 release ultimately may contribute to decreased neutrophil accumulation, persistence of bacteria in the lung, and increased severity of infection.lld:pubmed
pubmed-article:10570304pubmed:languageenglld:pubmed
pubmed-article:10570304pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10570304pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10570304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10570304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10570304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10570304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10570304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10570304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10570304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10570304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10570304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10570304pubmed:statusMEDLINElld:pubmed
pubmed-article:10570304pubmed:monthDeclld:pubmed
pubmed-article:10570304pubmed:issn0022-1767lld:pubmed
pubmed-article:10570304pubmed:authorpubmed-author:ChenYYlld:pubmed
pubmed-article:10570304pubmed:authorpubmed-author:HellewellP...lld:pubmed
pubmed-article:10570304pubmed:authorpubmed-author:Burke-Gaffney...lld:pubmed
pubmed-article:10570304pubmed:authorpubmed-author:BleaseKKlld:pubmed
pubmed-article:10570304pubmed:issnTypePrintlld:pubmed
pubmed-article:10570304pubmed:day1lld:pubmed
pubmed-article:10570304pubmed:volume163lld:pubmed
pubmed-article:10570304pubmed:ownerNLMlld:pubmed
pubmed-article:10570304pubmed:authorsCompleteYlld:pubmed
pubmed-article:10570304pubmed:pagination6139-47lld:pubmed
pubmed-article:10570304pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:meshHeadingpubmed-meshheading:10570304...lld:pubmed
pubmed-article:10570304pubmed:year1999lld:pubmed
pubmed-article:10570304pubmed:articleTitleLipoteichoic acid inhibits lipopolysaccharide-induced adhesion molecule expression and IL-8 release in human lung microvascular endothelial cells.lld:pubmed
pubmed-article:10570304pubmed:affiliationApplied Pharmacology and Unit of Critical Care, National Heart and Lung Institute Division, Imperial College School of Medicine, London, United Kingdom.lld:pubmed
pubmed-article:10570304pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10570304pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10570304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10570304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10570304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10570304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10570304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10570304lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10570304lld:pubmed